Indefinite Delivery Contract SPE2DB24D9120
Award Date
12/13/23
Last Date to Order
12/31/25
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
DMS Pharmaceutical Group Inc. was awarded a single award indefinite delivery contract by the Defense Logistics Agency Troop Support Medical to provide various pharmaceutical and medical supply items. The contract has a potential value of up to $4,999,999 and a period of performance through December 31, 2025.
Under the contract, DMS Pharmaceutical Group has received numerous firm fixed price delivery orders to supply products such as clindamycin injections, loperamide hydrochloride, selenium...
The Defense Logistics Agency has awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a variety of pharmaceutical and medical supplies. The single-award contract has a potential value of up to $4,999,999 and runs through December 31, 2025. Under this contract, DMS Pharmaceutical Group will deliver pharmaceutical items such as flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine...
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award indefinite delivery contract worth up to $499,999,999 from the Defense Logistics Agency (DLA). The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Key categories of goods to be delivered include prescription drugs,...
The Defense Logistics Agency (DLA) awarded DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, a single-award indefinite delivery contract valued at up to $499,999,999 through December 31, 2025. This contract, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical items including flumazenil injection, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, and other branded and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite delivery contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support military medical facilities worldwide. The IDC, valued up to $499,999,999, allows DLA to issue firm fixed-price delivery orders for common medications like antibiotics and cardiovascular drugs, as well as specialized...
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies on an as-needed basis. The contract has a potential value of $499,999,999 and a period of performance through December 31, 2025.
Task orders issued against the contract by DLA between January 18, 2023 and August 30, 2022 require DMS Pharmaceutical to deliver a variety of pharmaceutical products to locations in Park Ridge, Illinois. These...
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of Department of Defense programs. The IDV has a potential value of $499,999,999 and period of performance through December 2025.
Task orders issued against the contract include delivery of contraceptive implants, vaccines, injectable and topical medications, and other pharmaceutical products. DMS Pharmaceutical will provide...
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award indefinite delivery contract (IDC) by the Defense Logistics Agency (DLA) valued at up to $4,999,999 through December 31, 2025 under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for DMS Pharmaceutical Group to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to supply pharmaceutical products and medical supplies in support of Department of Defense healthcare programs. Delivery orders issued against the contract procured a range of prescription drugs, vaccines, medical implants and other supplies for distribution to military treatment facilities. Key products delivered included oncology pharmaceuticals, respiratory medications, contraceptives and...
DMS Pharmaceutical Group Inc., a woman-owned small business, was awarded a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 by the Defense Logistics Agency (DLA). The contract, number 4600082063, is for the procurement of a broad range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities supported by DLA worldwide. Products include tablets, capsules, injections, creams, solutions, and other drug forms spanning...